Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
Identifieur interne : 002151 ( PascalFrancis/Checkpoint ); précédent : 002150; suivant : 002152Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
Auteurs : Daniela Berg [Allemagne] ; Berthold Merz [Allemagne] ; Karlheinz Reiners [Allemagne] ; Markus Naumann [Allemagne] ; Georg Becker [Allemagne]Source :
- Movement disorders [ 0885-3185 ] ; 2004.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability.
Affiliations:
- Allemagne
- Bade-Wurtemberg, Bavière, District de Basse-Franconie, District de Tübingen
- Tübingen, Wurtzbourg
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:05-0225077Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease</title><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute for Medical Genetics, University of Tübingen</s1><s2>Tübingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Hertie Institue for Brain Research, University of Tiibingen</s1><s2>Tiibingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Tiibingen</wicri:noRegion><wicri:noRegion>University of Tiibingen</wicri:noRegion><wicri:noRegion>Tiibingen</wicri:noRegion></affiliation></author><author><name sortKey="Merz, Berthold" sort="Merz, Berthold" uniqKey="Merz B" first="Berthold" last="Merz">Berthold Merz</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Reiners, Karlheinz" sort="Reiners, Karlheinz" uniqKey="Reiners K" first="Karlheinz" last="Reiners">Karlheinz Reiners</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Naumann, Markus" sort="Naumann, Markus" uniqKey="Naumann M" first="Markus" last="Naumann">Markus Naumann</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Becker, Georg" sort="Becker, Georg" uniqKey="Becker G" first="Georg" last="Becker">Georg Becker</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, University of Homburg/Saar</s1><s2>Homburg/Saar</s2><s3>DEU</s3><sZ>5 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Homburg/Saar</wicri:noRegion><wicri:noRegion>University of Homburg/Saar</wicri:noRegion><wicri:noRegion>Homburg/Saar</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0225077</idno><date when="2004">2004</date><idno type="stanalyst">PASCAL 05-0225077 INIST</idno><idno type="RBID">Pascal:05-0225077</idno><idno type="wicri:Area/PascalFrancis/Corpus">001F21</idno><idno type="wicri:Area/PascalFrancis/Curation">000E00</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002151</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease</title><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute for Medical Genetics, University of Tübingen</s1><s2>Tübingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Hertie Institue for Brain Research, University of Tiibingen</s1><s2>Tiibingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Tiibingen</wicri:noRegion><wicri:noRegion>University of Tiibingen</wicri:noRegion><wicri:noRegion>Tiibingen</wicri:noRegion></affiliation></author><author><name sortKey="Merz, Berthold" sort="Merz, Berthold" uniqKey="Merz B" first="Berthold" last="Merz">Berthold Merz</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Reiners, Karlheinz" sort="Reiners, Karlheinz" uniqKey="Reiners K" first="Karlheinz" last="Reiners">Karlheinz Reiners</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Naumann, Markus" sort="Naumann, Markus" uniqKey="Naumann M" first="Markus" last="Naumann">Markus Naumann</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Becker, Georg" sort="Becker, Georg" uniqKey="Becker G" first="Georg" last="Becker">Georg Becker</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neurology, University of Homburg/Saar</s1><s2>Homburg/Saar</s2><s3>DEU</s3><sZ>5 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Homburg/Saar</wicri:noRegion><wicri:noRegion>University of Homburg/Saar</wicri:noRegion><wicri:noRegion>Homburg/Saar</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2004">2004</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Follow up study</term><term>Locus niger</term><term>Nervous system diseases</term><term>Parkinson disease</term><term>Sonography</term><term>Vulnerability</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Etude longitudinale</term><term>Locus niger</term><term>Parkinson maladie</term><term>Exploration ultrason</term><term>Vulnérabilité</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>20</s2></fA05><fA06><s2>3</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease</s1></fA08><fA11 i1="01" i2="1"><s1>BERG (Daniela)</s1></fA11><fA11 i1="02" i2="1"><s1>MERZ (Berthold)</s1></fA11><fA11 i1="03" i2="1"><s1>REINERS (Karlheinz)</s1></fA11><fA11 i1="04" i2="1"><s1>NAUMANN (Markus)</s1></fA11><fA11 i1="05" i2="1"><s1>BECKER (Georg)</s1></fA11><fA14 i1="01"><s1>Institute for Medical Genetics, University of Tübingen</s1><s2>Tübingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Hertie Institue for Brain Research, University of Tiibingen</s1><s2>Tiibingen</s2><s3>DEU</s3><sZ>1 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Neurology, University of Würzburg</s1><s2>Würzburg</s2><s3>DEU</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></fA14><fA14 i1="04"><s1>Department of Neurology, University of Homburg/Saar</s1><s2>Homburg/Saar</s2><s3>DEU</s3><sZ>5 aut.</sZ></fA14><fA20><s1>383-385</s1></fA20><fA21><s1>2004</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000129522560190</s5></fA43><fA44><s0>0000</s0><s1>© 2005 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>10 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>05-0225077</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC02 i1="03" i2="X"><s0>002B17A03</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Etude longitudinale</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Follow up study</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Estudio longitudinal</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Locus niger</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Locus niger</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Locus níger</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Exploration ultrason</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Sonography</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Exploración ultrasonido</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Vulnérabilité</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Vulnerability</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Vulnerabilidad</s0><s5>06</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso central</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>40</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>41</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>41</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>41</s5></fC07><fN21><s1>157</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Allemagne</li></country><region><li>Bade-Wurtemberg</li><li>Bavière</li><li>District de Basse-Franconie</li><li>District de Tübingen</li></region><settlement><li>Tübingen</li><li>Wurtzbourg</li></settlement></list><tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name></region><name sortKey="Becker, Georg" sort="Becker, Georg" uniqKey="Becker G" first="Georg" last="Becker">Georg Becker</name><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><name sortKey="Merz, Berthold" sort="Merz, Berthold" uniqKey="Merz B" first="Berthold" last="Merz">Berthold Merz</name><name sortKey="Naumann, Markus" sort="Naumann, Markus" uniqKey="Naumann M" first="Markus" last="Naumann">Markus Naumann</name><name sortKey="Reiners, Karlheinz" sort="Reiners, Karlheinz" uniqKey="Reiners K" first="Karlheinz" last="Reiners">Karlheinz Reiners</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002151 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 002151 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:05-0225077
|texte= Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |